Details of the Drug-Related molecule(s) Interaction Atlas

Z90308237 Drug Info

SCHEMBL18352966; BDBM113300; ZINC12619607; AKOS034677493; MCULE-1271453362; US9695194, 16; Z90308237; 1000928-01-7; 5-(2-chlorophenyl)-6,11,14-trioxa-4-azatricyclo[8.4.0.0^{3,8}]tetradeca-1,3(8),4,9-tetraen-7-one

Cross-matching ID

PubChem CID

25400532

TTD Drug ID

DMRBFUA

General Information of Drug (ID: DMRBFUA)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Chymotrypsin-C (CLCR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Z223457004	DMUOZEJ	N. A.	N. A.	Patented	[1]
STK296197	DM6KPYL	N. A.	N. A.	Patented	[1]
AC1LCOK0	DMFWYKE	N. A.	N. A.	Patented	[1]
PMID12372533C20	DMIW5TY	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Benzoxazinone derivatives for treatment of skin diseases. US9695194.
2	P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3199-202.